Managing Pharmacy Benefits in Today's Economy: Strategies To Help Stretch Pharmacy Benefit Dollars
Managing Pharmacy Benefits in Today's Economy: Strategies To Help Stretch Pharmacy Benefit Dollars
Pharmacy Benefits
When discussing cost management for pharmacy benefits, one of the key strategies has
been and will remain generic formulations of
branded medications. Industry sources estimate
that more than $20 billion in popular and
expensive drugs such as Avandia (diabetes);
Flomax (enlarged prostate); Lipitor (high
cholesterol); Valtrex (herpes); and Prevacid
(heartburn) are expected to become generically
available over the next three years.'
The good news is that employers and
employees today understand the value of generics. Nearly two billion prescriptions are filled
with generic medicines every year. In 2008,
generic medicines were used to fill 65 percent
of all prescriptions dispensed.2 Despite this fact,
generics only account for 16 percent of the
annual drug spend. 3
The cost saving potential of generics continues to be significant and therefore well worth
maximizing. The average cost of a typical
generic prescription is 30 to 80 percent less than
its branded counterpart, saving consumers from
$8 to $10 billion a year at retail pharmacies. 4
While many employers have already implemented strong generic programs and achieved
high utilization rates, there are a number of
strategies to be explored and implemented to
create further cost savings.
Recognizing the complexity of the marketplace, some pharmacy benefit managers (PBMs)
offer multi-tiered generic formularies or incorporate other strategies to lower overall medication
costs. The key to a successful generic medication
program is to emphasize and promote the total
health management of the patient.
Even this approach may prove complex
in some instances. Because no two individuals are the same, what may be therapeutically
appropriate for one individual with a certain
disease, may not be optimal for another with
the same condition. For example,
Angiotensin-Converting Enzyme, or ACE
inhibitors are a group of medications that
20 JULY 2009
Pharmacy Benefits
are used primarily in the treatment
of hypertension (high blood pressure) and congestive heart failure,
or to slow progression of kidney
disease among patients with diabetes. There are multiple generic
options available within this therapeutic category, making it one of
the more commonly prescribed
medications. Similarly, Angiotensin
II Receptor Antagonists, also known
as Angiotensin Receptor Blockers
(ARBs), are a group of medications
that are also used to treat similar
indications as for ACE inhibitors.
However, ARBs have no generic
equivalents and thus the cost difference between ACE and ARBs can be
significant. Therefore, the question for
physiciansas well as for plan sponsors working with PBMs to manage
costsis when to use which medication. In most cases, the ACE inhibitor
will provide the desired therapeutic
outcomes. However, some patients
who are unable to tolerate ACE
inhibitor therapy and thus would not
be able to gain medical benefit from
such therapy. These patients may
benefit from ARB therapy in place of
an ACE inhibitor. PBMs can utilize
step therapy programs to effectively
manage the appropriate use of these
medications for its plan members.
Under a step therapy program,
unless clinically indicated, patients
first have access to lower cost
medications with proven efficacy. If
desired therapeutic outcomes are not
achieved, then they will be approved
to receive a higher cost drug alternative. Step therapy programs
work best when they also include a
clinically focused prior authorization
component that will allow physicians
to immediately override a generic or
even preferred branded medication in
exchange for the medication that the
prescriber believes is most appropriate for his or her patient.
S1 AATEGY KEY TO
EFFECTIVE GENERIC
PROGRAMS
JULY 2009
21
Pharmacy Benefits
Mail service is not for every
employee. It works best for chronic
medications such as those for
hypertension, heart disease, or diabetes management. However, when
used as part of a comprehensive
pharmacy program, it can provide
key benefits to employers and
employees. Employers can achieve
savings of up to 10 percent when
employees use mail service, representing millions of dollars for largeto mid-size employers. Employees
can save as well, particularly those
on branded medications or with
tiered generic copayments. In addition, workers can secure the added
benefit of convenience and with
leading mail service pharmacies,
the ability to talk 24/7 directly and
privately to a pharmacist by phone
or e-mail.
While mail service and generics represent two important areas
to address in cost saving programs,
there are other options to consider as
well. Employers seeking to maintain
quality and control costs should also
consider the following steps.
STEPS TO TAKE
FOR COST SAVINGS
AND QUALITY CARE
22
JULY 2009
Encourage Compliance
It is estimated that about onehalf of consumers are noncompliant
Conduct Prescription
Reviews with Physicians and
Pharmacists
Periodic prescription medication reviews help to ensure patients
are only on those medications that
provide desired medical outcomes.
Over the years, and particularly
if they are seeing more than one
physician, employees may be taking
medications which they no longer
need, potentially placing them at
risk for polypharmacy. Or, they may
be taking drugs for which there are
more effective alternatives. Ensuring
that physicians and/or pharmacists
review all medications can help
to ensure safe, appropriate and
effective prescription utilization.
Employees, physicians, and pharmacists alike should be encouraged to
periodically review all medications
a patient is takingincluding overthe-counter (OTC) nonprescription
medications.
Pharmacy Benefits
Communicate
A central component of virtu ally every proven pharmacy ben efit strategy is communication.
Whether it's an employee talking to
his or her physician about generic
options; a PBM talking to physicians about patients that might
benefit from specific medication
therapies; or pharmacists suggesting a lower cost but therapeutically
equivalent medication, communication about pharmacy benefits
will be key in managing pharmacy
benefit costs in the coming months
and years. All stakeholders in the
system need to feel empowered to
ask questions, share concerns and
provide alternatives in an effort to
improve quality and control
costs.
Today's volatile economy will continue to place a burden on employers to find ways to reduce spending.
While health care reform is coming,
its exact timing, form, scope, and
effect are largely unknown and may
come incrementally. Employers struggling to survive need programs that
can provide real value and cost savings today.
Strengthening existing programs
particularly those promoting
generic medications and utiliza tion
of sophisticated mail service
pharmaciesand emphasizing
education, communication, and collaboration with all stakeholders are
steps that can be taken now and
that will provide real results today
and tomorrow.
1.
2.
3.
4.
See http://drugtopics.modernmedicine.com/
drugtopics/data/articlestandardll
drugtopics/172008/511856/article.pdf.
See http://www.gphaonline.org/aboutgpha/about-generics/facts.
See http://www.modernmedicine.
com/modernmedicine/Top +news/
Insurance-companies-urging-switch-togenerics/ArticleStandard/Article/detail/
572094 ?searchString=generics%20spending.
Ibid.
NOTES
W OR T H T HE " EF"'""oRT
JULY 2009
23
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.